This video is awesome. The takeaway though is not I must hire someone who can replicate this.
The half life of new growth tactics alpha is shorter than ever.
The really rare talent is those that can look at the way channels and content are moving and design the next system
I hope this point about subsidising product quality is true but I just haven’t seen any evidence of it yet.
It seems to be that agents are working more like the “I’m feeling lucky” Google search result, embedding an SEO advantage, and likely one consumers are going to trust even more because it’s presented as an answer rather than a set of options.
Assorted things I've been mulling over regarding agents in the economy:
• Companies are in some sense the original superintelligence. It's often the case that they can use their amortized cognitive surplus to advance their interests against those of certain consumers: relative to the optimization capacity of companies, consumers can be inattentive, underinformed, irrational, etc. (Think, say, of some of the classic insurance upsells at the end of a booking process, which is typically priced substantially above what a regular policy would cost.) Herbert Simon introduced the idea of bounded rationality, and firms often end up benefiting from it. Thanks to personal agents, we will probably get somewhat more rational in how we engage with companies.
• How exactly will outcomes change? Well, certain kinds of price discrimination will work less well (how do coupons work if every agent hunts fastidiously for them?), and certain kinds of customer cross-subsidy will change (today, people who forget to cancel subscriptions subsidize those who don't). Taken across the economy as a whole, I'm not sure what the incidence of all of this will be.
• In corporate strategy, people have long debated the relative importance of distribution and product quality. Perhaps you've made something better, but does anyone know about it? Won't people just continue to buy the ACME Corp Mousetraps? Personal agents will, I think, act as a kind of structural subsidy for product quality. How would markets look different if individuals always spent at least 10 hours researching their purchases? On the margin, focusing on making a product better is, I think, going to become a more effective strategy for companies. This is good!
• It true, a corollary is that information about product quality will become more important and impactful. Today, most people have very limited ability to aggregate and integrate such data, but agents will have insatiable thirst for such signals. (It's often said that data is becoming more valuable because it helps in the training of models. That's obviously true, but I think there's a secondary way in which it's more valuable simply as a complement to cheaper intelligence.)
• A big question is whether agents will increase superstar effects (rational agents all settle on the same product) or increase dispersion (because everyone has slightly different tastes and preferences, which agents are good at eliciting, finally overcoming the artificial clustering we've been subjected to).
• Many internet companies have monetized demand routing, which is in turn often predicated on short attention spans. "I'll click on the first thing I see." This has led to some amount of inefficiency, as companies try to propitiate capricious ranking algorithms and incur various placement fees. It's not all deadweight loss (willingness to pay is itself a kind of signal, which is valuable to buyers), but it's not great. How will the nature and value of this routing change in a world of personal agents? I don't know the answer, but I think that the effects might be pretty big.
• Much of what I'm writing hinges on the assumption that personal agents will be on the consumer's side. I suspect that that will be the winning strategy, but whether it's true, and what it means to be true, involves a lot of other questions.
Taken as a whole, the market is a massively parallelized, decentralized, and highly imperfect value attribution machine, and, taking stock of all of the effects, it seems to me that the quality point may well be the biggest: that agents will change the nature of the backpropagation such that the rewards for better products increase. Maybe this is too optimistic, but I suspect (and hope) that companies that make things that they're proud of will feel that the universe is a little more partisan in their favor.
Men’s health has changed a lot in the seven years since we founded Pilot.
There was a widespread belief that men did not care about their health, and that solving for discretion and convenience was the only way to reach them.
That world has changed. Men care more, expect more and understand that the investments they make in their health pay off in how they feel, how they look and how they perform.
Today, Pilot becomes Hims, and we’re raising our ambition to meet the needs of Australian men through personalised preventative care.
I co-founded Eucalyptus on the belief that healthcare’s biggest opportunity isn’t the hospital—it’s everything that happens before you need one. That’s the same belief we’re taking into this next phase of growth.
Current Pilot customers will keep the local care team they already trust. They’re now part of a platform serving millions of men worldwide.
I’m proud of what we’ve built and excited for what’s next: news.hims.com/newsroom/hims-…
The NYSE welcomes Hims & Hers to celebrate its 5th anniversary of listing! $HIMS
@wearehims | @wearehers xitter.cf/i/broadcasts/1jGXgBBRW…
More than anything else, @AndrewDudum & the @wearehims team showed us that world-class healthcare could be built with the patient at the centre of every decision.
Five years ago that meant meeting people where they were and removing friction to high quality care.
Five years from now, a Hims & Hers membership will be how we monitor our health, seek advice from practitioners who get it, and manage treatments that improve our lives.
Our team at Eucalyptus couldn't be more excited to help build that future.
Today, we closed our acquisition of Eucalyptus, advancing our position as the world’s largest consumer health platform.
When @_Timdoyle and I first met, healthcare looked very different (and so did our lives - I was a first-time dad, still on paternity leave when we had our first lunch). Proactive healthcare still felt niche and the concept of direct-to-consumer access was misunderstood as a trend.
Five years later, the world has changed (and so has life – I’m now a dad to three boys, and Tim’s a father, too). People are no longer willing to navigate through arbitrary barriers for the simplest kinds of care. Healthcare innovators like drugmakers and diagnostic companies have realized connecting directly with individuals is the most powerful way to grow.
But what has stayed the same is how aligned Tim and I are on what the future of health can and should be. It’s simple, deeply personal, and built for everyday life. It became clear at the end of last year that the time has never been more right to come together.
Today, we’re operating as one company, focused on reaching millions of people around the world with a version of health that feels like a luxury, but doesn’t cost like one. Combining Eucalyptus’ local expertise with our scale means we can serve millions of people around the world and expand the network effects of the platform. We’ll become an everyday health companion and a partner to other healthcare innovators who want to build long-term relationships with their customers.
I told the entire team this morning: The most enduring consumer companies are the ones that create a completely new way of experiencing the most personal parts of our lives. My kids deserve a different version of health than I got. So do Tim’s. So do yours. That’s what we’re building at Hims & Hers and I can’t wait for the world to see what’s possible.
news.hims.com/newsroom/how-w…
Read more here, including important footnotes and disclaimers: investors.hims.com/news/news…
youtube.com/watch?v=euK9To49…
I think this is the first time i've been on a podcast where the hosts were incredibly deep in the weeds of running a modern digitally native brand.
It was a real pleasure, a great conversation and I learned a lot, so hopefully it will be a valuable listen.
Thanks @AaronOrendorff for having me
Most bullish thing OpenAI have done since o3
ChatGPT launches a CAPI, a pixel, and self-serve
"It’s not hard to imagine how the ad platform evolves from here. OpenAI is almost assuredly building a platform in the image of Meta’s, which means it will cater the platform to the needs of SMBs, particularly eCommerce and retail advertisers."
mobiledevmemo.com/chatgpt-la…
We're joining @wearehims to build the world's great preventative health business.
What I think separates @AndrewDudum and his team from the endless list of businesses pursuing this, is the understanding and ability to serve the average person.
The average person wants simplicity. Make it simple for them to understand their health, provide simple, empathetic advice and make it easy to take action.
If you can do that, patients will stick around, and their health will improve.
Tim Doyle retweeted
Today, we’re on the fast track to becoming the leading global consumer health platform: we’ve agreed to acquire Eucalyptus, an international innovator in digital health.
We’ve spent several years investing in our international footprint because we know that the status quo in healthcare across the world still doesn’t put the individual at the center. When I met @_Timdoyle many years ago, I knew immediately that we shared a similar perspective on how to change the status quo.
Helping people feel great means tackling multiple conditions and recognizing that one size doesn’t fit all. It requires a diversified platform that can meet almost anyone where they are with care that is built for them. It’s what makes Tim and his team leaders outside the US, and it’s why we’ve made the decision to welcome them to Hims & Hers after closing. Their dedication to consumers has resulted in an incredible business with an ARR north of $450 million USD that delivered triple-digit year-over-year ARR growth every quarter last year.
Together, we’re going to push the industry to put people at the center of healthcare and help more people experience care that feels like a luxury without costing like one.
I have always known the value of what we’re building for customers at Hims & Hers isn’t restricted to borders. That’s even more true today.
Read more here, including important footnotes and disclaimers: investors.hims.com/news/news…
OpenAI should buy ROKT imo, feels like the right ad unit + a mostly functioning buying platform, would solve a big problem.
Running and golf two resurgent activities among younger people. Social, time spent outside, long duration? Anything other examples?
Tim Doyle retweeted
Grit isn’t showing up in the office 9-9-6 when the VC dollars are flowing and ACV doubles every week; it’s pushing through and showing up when everything is falling apart but you still believe
Consumer retention often gets a bad wrap, i'm often surprised by how well the long tail holds up, this is our first ever two cohorts in Pilot.
Lot of GeZ founders in hype above all else mode. This is grounded in a lack of understanding of marketing. There is almost no downside to attention when you are trying to build an influencer career. There is a lot downside to flowing hype in a bad product.
So you're either deluding yourself with consumers that are the strangest on earth, or you are flowing your ICP into a bad product, both seem like bad ideas.










